Search for Clinical Trial Results
Pancreatic Neuroendocrine Tumor - 45 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2014-09-02 Interventions:
|
Completed |
Study Name: 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2014-06-03 Interventions: Drug: 68Ga-OPS202 |
Recruiting |
Study Name: 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2013-04-25 Interventions: Drug: Intravenous injection of 177Lu-octreotate Treatment will consist of 177Lu-octreotate injections in |
Completed |
Study Name: Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs Condition: Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System Date: 2010-12-16 Interventions:
|
Not yet recruiting |
Study Name: TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors Condition:
|
Recruiting |
Study Name: Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors Condition:
|
Active, not recruiting |
Study Name: The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases Condition:
|
Recruiting |
Study Name: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Condition:
|
Enrolling by invitation |
Study Name: Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan Condition: This Study Plans to Include 600 GEP-NET Patients. Date: 2014-02-27 |
Not yet recruiting |
Study Name: Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival Condition: Pancreatic Neuroendocrine Tumor Date: 2015-11-30 Interventions: Procedure: pancreatectomy Remove the pancreatic neuroendocrine tumor by surgery |